Top Markets
Coin of the day
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
주식 순위 #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
주가
$93.80
마지막 동기화: 2025-04-28
시가총액
$2.68B
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Aerovate Therapeutics, Inc. (AVTE)

카테고리

Aerovate Therapeutics, Inc. (AVTE)의 주가 이력
최고 종가: $92.05 (2025-04-01 기준)

최저 종가: $799.05 (2021-06-01 기준)
Aerovate Therapeutics, Inc.의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2025 1.25%
2024 -86.27%
2023 -23.84%
2022 125.16%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$549.38 41.20%
US
$1.05K 47.75%
NL
$148.35 491.02%
US
$122.63 -12.65%
AU
$762.91 6.87%
CH